← All organizations
Highest phase reached
Phase 4
First clinical trial
May 1, 2004Last known activity
Dec 31, 2022
Timeline
1940s
- Nov 6, 1946
SRI International— Founded
Drugs by trial phase (12 distinct, 9 trials)
Phase 2 (4 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
- Alphavirus Infections
- Brain Diseases
- Breast Neoplasms
- Central Nervous System Diseases
- Central Nervous System Infections
- Central Nervous System Viral Diseases
- Chikungunya Fever
- Communicable Diseases
- Encephalitis
- Encephalitis, Viral
- Encephalomyelitis
- Encephalomyelitis, Equine
- Encephalomyelitis, Venezuelan Equine
- Hypertension
- Infections
- Infectious Encephalitis
- Nervous System Diseases
- Parasomnias
- RNA Virus Infections
- Sleep Wake Disorders
- Togaviridae Infections
- Virus Diseases
Recent trials (12)
- NCT05628961Overall official - principal investigatorPhase 1Dec 31, 2022
- NCT05628961Lead sponsorPhase 1Dec 31, 2022
- NCT03776994Overall official - principal investigatorPhase 1Jul 17, 2018
- NCT03776994Lead sponsorPhase 1Jul 17, 2018
- NCT03522935CollaboratorPhase 1May 15, 2018
- NCT02787356Lead sponsorN/AOct 1, 2017
- NCT02861586CollaboratorPhase 2Aug 1, 2016
- NCT00672438CollaboratorN/AMay 1, 2008
- NCT00301145Lead sponsorN/AOct 1, 2005
- NCT00301145Study chairN/AOct 1, 2005
- NCT00132821Overall official - principal investigatorPhase 4Aug 1, 2005
- NCT00166543Lead sponsorPhase 2May 1, 2004
Details
- Founded
- Menlo Park, CA, US Nov 6, 1946
- Last known activity
- Dec 31, 2022